Platyphylline Solution for Injection, 2 Mg/ml, 1 Tender - 148092226

Procurement Summary

Country: Ukraine

Summary: Platyphylline Solution for Injection, 2 Mg/ml, 1 Ml Each (platyphylline); Meloxicam Solution for Injection 10 Mg/ml in 1.5 Ml (meloxicam); Ascorbic Acid Solution for Injection, 100 Mg/ml in 2 Ml (ascorbic Ac...

Deadline: 31 Aug 2026

Posting Date: 28 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 148092226

Document Ref. No.: UA-2026-08-26-012294-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 122429.9

CPV Classification

33600000 - Pharmaceutical products
33610000 - Medicinal products for the alimentary tract and metabolism
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Platyphylline solution for injection, 2 mg/ml, 1 ml each (Platyphylline); Meloxicam solution for injection 10 mg/ml in 1.5 ml (Meloxicam); Ascorbic acid solution for injections, 100 mg/ml in 2 ml doses (Ascorbic acid (vit C)); Urapidil solution for injection 5 mg/ml in 5 ml doses (Urapidil); Calcium gluconate tablets 500 mg (Calcium gluconate); Calcium gluconate solution for injections 100 mg/ml in 10 ml (Calcium gluconate); Ketorolac solution for injection, 30 mg/ml, 1 ml each (Ketorolac); Diosmin (combinations), tablets, 1000 mg each (Diosmin, combinations); Nicotinic acid solution for injections 10 mg/ml in 1 ml (Nicotinic acid); Boric acid, crystalline powder, 10 g (Boric acid); Hydrogen peroxide, solution, 3%, 100 ml each (Hydrogen peroxide); Progesterone vaginal tablets of 100 mg (Progesterone); Ambroxol tablets of 30 mg (Ambroxol); Moxonidine tablets of 0.2 mg (Moxonidine); Ursodeoxycholic acid capsules/tablets of 500 mg (Ursodeoxycholic acid); Simethicone oral suspension/Oral drops, emulsion, 40 mg/ml, 30 ml each (Silicones); Etamsylate solution for injection, 125 mg/ml in 2 ml (Etamsylate); Aminocaproic acid, solution for infusions, 50 mg/ml, 100 ml each (Aminocaproic acid); Nefopam, solution for injection, ...

Documents

 Tender Notice